Timothy P. Heffron

2.6k total citations
21 papers, 808 citations indexed

About

Timothy P. Heffron is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Timothy P. Heffron has authored 21 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Timothy P. Heffron's work include Synthetic Organic Chemistry Methods (6 papers), Glioma Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Timothy P. Heffron is often cited by papers focused on Synthetic Organic Chemistry Methods (6 papers), Glioma Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Timothy P. Heffron collaborates with scholars based in United States, France and Switzerland. Timothy P. Heffron's co-authors include Timothy F. Jamison, Graham L. Simpson, Estı́baliz Merino, Scott L. DuVall, Bert L. Lum, Leslie Z. Benet, Scott N. Holden, Joseph A. Ware, Adam Frymoyer and Laura Chu and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Timothy P. Heffron

21 papers receiving 783 citations

Peers

Countries citing papers authored by Timothy P. Heffron

Since Specialization

Citations

This map shows the geographic impact of Timothy P. Heffron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy P. Heffron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy P. Heffron more than expected).

Fields of papers citing papers by Timothy P. Heffron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy P. Heffron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy P. Heffron. The network helps show where Timothy P. Heffron may publish in the future.

Co-authorship network of co-authors of Timothy P. Heffron

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy P. Heffron. A scholar is included among the top collaborators of Timothy P. Heffron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy P. Heffron. Timothy P. Heffron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of KRAS G12C Target Engagement by a Covalent Inhibitor in Tumor Biopsies Using an Ultra-Sensitive Immunoaffinity 2D-LC–MS/MS Approach 2022 ·Analytical Chemistry ·(unknown), Emily Chan, Carl Ng, Junko Aimi, John C. Tran, Angela Oh, Mark Merchant, Hans E. Purkey, Timothy P. Heffron, Surinder Kaur, Keyang Xu, Zhen Shi, Jintang He	7
2	Characterization of Antineovascularization Activity and Ocular Pharmacokinetics of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GNE-947 2020 ·Drug Metabolism and Disposition ·Xingrong Liu, Xiaorong Liang, (unknown), Savita Ubhayakar, Jacob Chen, (unknown), Tom Lee, (unknown), Jim Nonomiya, Sheerin Shahidi-Latham, (unknown), Eric Solon, Matthew Wright, Cornelis E. C. A. Hop, Timothy P. Heffron	5
3	Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer 2018 ·Structure ·Ping Wu, Christopher J. Sneeringer, Keith Pitts, Eric S. Day, Bryan Chan, BinQing Wei, Isabelle Lehoux, Kyle Mortara, Hong Li, Jian Wu, Yvonne Franke, John G. Moffat, Jane L. Grogan, Timothy P. Heffron, Weiru Wang	30
4	CNS Anticancer Drug Discovery and Development: 2016 conference insights 2017 ·CNS Oncology ·Victor A. Levin, Lauren E. Abrey, Timothy P. Heffron, Peter J. Tonge, Arvin C. Dar, William A. Weiss, James M. Gallo	8
5	Challenges of developing small-molecule kinase inhibitors for brain tumors and the need for emphasis on free drug levels 2017 ·Neuro-Oncology ·Timothy P. Heffron	32
6	Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR 2016 ·ACS Medicinal Chemistry Letters ·Timothy P. Heffron, Chudi Ndubaku, Laurent Salphati, Bruno Alicke, Jonathan Cheong, Joy Drobnick, Kyle A. Edgar, Stephen E. Gould, Leslie B. Lee, John Lesnick, Cristina Lewis, Jim Nonomiya, Jodie Pang, Emile G. Plise, Steve Sideris, Jeffrey J. Wallin, Lan Wang, Xiaolin Zhang, Alan G. Olivero	76
7	Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer 2016 ·Journal of Medicinal Chemistry ·Timothy P. Heffron	84
8	4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase 2015 ·Bioorganic & Medicinal Chemistry Letters ·Emily J. Hanan, (unknown), Marian C. Bryan, Yuan Chen, Charles Eigenbrot, Peter W. Fan, (unknown), Hank La, Shiva Malek, Hans E. Purkey, Gabriele Schaefer, Stephen Schmidt, Steve Sideris, Ivana Yen, Christine Yu, Timothy P. Heffron	39
9	A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery 2015 ·Journal of Computer-Aided Molecular Design ·Ignacio Aliagas, Alberto Gobbi, Timothy P. Heffron, Man‐Ling Lee, Daniel F. Ortwine, Mark Zak, S. Cyrus Khojasteh	23
10	CNS Anticancer Drug Discovery and Development Conference White Paper 2015 ·Neuro-Oncology ·Victor A. Levin, Peter J. Tonge, James M. Gallo, Marc R. Birtwistle, Arvin C. Dar, Antonio Iavarone, Patrick J. Paddison, Timothy P. Heffron, William F. Elmquist, Jean E. Lachowicz, Ted W. Johnson, Forest M. White, Joohee Sul, Quentin R. Smith, Shen Wang, Jann N. Sarkaria, Ramakrishna Samala, Patrick Y. Wen, Donald A. Berry, Russell C. Petter	34
11	Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development 2013 ·Molecular Pharmaceutics ·(unknown), Timothy P. Heffron, Laura Chu, Brian Dean, (unknown), Scott L. DuVall, Bert L. Lum, Nageshwar Budha, Scott N. Holden, Leslie Z. Benet, Adam Frymoyer, Mark J. Dresser, Joseph A. Ware	147
12	Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M 2012 ·Cancer Discovery ·Ho‐June Lee, Gabriele Schaefer, Timothy P. Heffron, Lily Shao, Xiaofen Ye, Steve Sideris, Shiva Malek, Emily Chan, Mark Merchant, Hank La, Savita Ubhayakar, Robert L. Yauch, Valentina Pirazzoli, Katerina Politi, Jeff Settleman	68
13	Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase 2012 ·Bioorganic & Medicinal Chemistry Letters ·Steven T. Staben, Nicole Blaquière, Vickie Tsui, Aleksandr Kolesnikov, Steven Do, Erin K. Bradley, Jenna Dotson, Richard Goldsmith, Timothy P. Heffron, John Lesnick, Cristina Lewis, Jeremy Murray, Jim Nonomiya, Alan G. Olivero, Jodie Pang, Lionel Rougé, Laurent Salphati, BinQing Wei, Christian Wiesmann, Ping Wu	5
14	DEGAS: Sharing and Tracking Target Compound Ideas with External Collaborators 2011 ·Journal of Chemical Information and Modeling ·Man‐Ling Lee, Ignacio Aliagas, Jennafer Dotson, Jianwen A. Feng, Alberto Gobbi, Timothy P. Heffron	12
15	Ladder Polyether Synthesis via Epoxide-Opening Cascades Directed by a Disappearing Trimethylsilyl Group 2010 ·The Journal of Organic Chemistry ·Timothy P. Heffron, Graham L. Simpson, Estı́baliz Merino, Timothy F. Jamison	21
16	ChemInform Abstract: Identification of GNE‐477 (I), a Potent and Efficacious Dual PI3K/mTOR Inhibitor. 2010 ·ChemInform ·Timothy P. Heffron, (unknown)	1
17	Concerning Lewis Acid Promoted, Directing-Group-Free Epoxide-Ring-Opening Cascades 2006 ·Synlett ·Timothy F. Jamison, Timothy P. Heffron	1
18	SiMe₃-Based Homologation−Epoxidation−Cyclization Strategy for Ladder THP Synthesis 2003 ·Organic Letters ·Timothy P. Heffron, Timothy F. Jamison	64
19	Synthesis of skipped enynes via phosphine-promoted couplings of propargylcopper reagents 2003 ·Tetrahedron ·Timothy P. Heffron, (unknown), Timothy F. Jamison	25
20	Application of Reactive Enols in Synthesis: A Versatile, Efficient, and Stereoselective Construction of the Welwitindolinone Carbon Skeleton 1999 ·Journal of the American Chemical Society ·John L. Wood, (unknown), Brian M. Stoltz, Matthew M. Weiss, Julie A. Dixon, Brian D. Doan, (unknown), Jennifer M. Chen, Timothy P. Heffron	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact